Alliance's Bens Offers Testimony on MDUFA before House Committee
Author: Cynthia Bens
Date: March 28th, 2017
Today, the Alliance for Aging Research's Vice President of Public Policy Cynthia Bens testifed before the U.S. House of Representatives' Energy and Commerce Committee, Subcommittee on Health, in regard to reauthorization of the Medical Device User Fee Act (MDUFA).
Alliance's Bens Will Testify on MDUFA and PDUFA Reauthorization
Author: Breanna Bishop
Date: April 3rd, 2017
On April 4, the Alliance for Aging Research’s Vice President of Public Policy Cynthia Bens will testify before the U.S. Senate Committee on Health, Education, Labor and Pensions about the reauthorization of the Prescription Drug User Fee Act and the Medical Device User Fee Act. You can watch the hearing here.
Alliance Comments on the FDA's Commitment Letter for PDUFA VI
Author: Noel Lloyd
Date: August 30th, 2016
In response to a call from the U.S. Food and Drug Administration (FDA) for feedback on its proposed Commitment Letter for the sixth reauthorization of the Prescription Drug User Fee Act (PDUFA), the Alliance for Aging Research submitted comments to the FDA for consideration.
Alliance Offers Comments on FDA OTC Monograph User Fees
Author: Noel Lloyd
Date: June 15th, 2016
Last Friday, on June 10, Vice President of Public Policy Cynthia Bens presented comments on behalf of the Alliance at a U.S. Food and Drug Administration public meeting focused on OTC monograph user fees.
PDUFA V Can Help Patients and the FDA
Author: Dan Perry
Date: June 30th, 2011
On June 26, 2011 I was interviewed by BioCentury This Week to share the Alliance for Aging Research’s impressions on the fifth reauthorization of the Food and Drug Administration’s Prescription Drug User Fee program. Thanks to Congress, we and other active patient groups were able to lend an early voice in helping to shape how user fees might be used to help speed the delivery of better treatments and cures to patient in need of relief from Alzheimer’s, Cancer, Parkinson’s and many more diseases.